Evidence map›Paper›PMID 34216675›Full record

ArticleKidney international2021

Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.

Didier Ducloux, Mathilde Colladant, Melchior Chabannes, Maria Yannaraki, Cécile Courivaud

Abstract readLetter
In one paragraph

Article in Kidney international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Didier DuclouxDepartment of Nephrology, Dialysis, and Renal Transplantation, Centre Hospitalo-Universitaire Besançon, Besançon, France; Federation Hospitalo-Universitaire INCREASE, Besançon, France. Electronic address: didier.ducloux@univ-fcomte.fr.
Mathilde ColladantDepartment of Nephrology, Dialysis, and Renal Transplantation, Centre Hospitalo-Universitaire Besançon, Besançon, France; Federation Hospitalo-Universitaire INCREASE, Besançon, France.
Melchior ChabannesDepartment of Nephrology, Dialysis, and Renal Transplantation, Centre Hospitalo-Universitaire Besançon, Besançon, France; Federation Hospitalo-Universitaire INCREASE, Besançon, France.
Maria YannarakiDepartment of Nephrology, Dialysis, and Renal Transplantation, Centre Hospitalo-Universitaire Besançon, Besançon, France; Federation Hospitalo-Universitaire INCREASE, Besançon, France.
Cécile CourivaudDepartment of Nephrology, Dialysis, and Renal Transplantation, Centre Hospitalo-Universitaire Besançon, Besançon, France; Federation Hospitalo-Universitaire INCREASE, Besançon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 VaccinesBNT162 VaccineHumansRenal DialysisRNA, MessengerSARS-CoV-2BNT162 VaccineCOVID-19 VaccinesRNA, Messenger

Identifiers

PMID34216675
PMCPMC8243640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.